Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Candel Therapeutics logo

Candel Therapeutics

Recent Finacing

Equity

Recent Raise

$130M

Candel Therapeutics is a clinical-stage biopharmaceutical company developing off-the-shelf viral immunotherapies that activate the immune system against solid tumors.

Massachusetts, United States
11-50
Publicly Traded
candeltx.com
PitchBook

Highlights

Focus Areas

Biotechnology
Genetics
Health Care
Health Diagnostics
Medical
Therapeutics

Recent Investors

Trinity Capital logo
PBM Capital logo
L
H
Sands Capital logo
Northpond Ventures logo

Financials

$181.2M

Total Raised

3

Funding rounds

6

Investors


Team

Upgrade to view the team

See the team members at Candel Therapeutics.